These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24602173)

  • 1. Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy.
    Lu X; Li M; Zhou L; Jiang H; Wang H; Chen J
    Nephrology (Carlton); 2014 Jun; 19(6):307-17. PubMed ID: 24602173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum- and glucocorticoid-inducible kinase 1 in doxorubicin-induced nephrotic syndrome.
    Artunc F; Nasir O; Amann K; Boini KM; Häring HU; Risler T; Lang F
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1624-34. PubMed ID: 18768591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
    Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
    Rong ZH; Wang C; Hao J; Duan HJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):275-8. PubMed ID: 18471357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy.
    Tomioka M; Hiromura K; Sakairi T; Takeuchi S; Maeshima A; Kaneko Y; Kuroiwa T; Takeuchi T; Nojima Y
    Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-sensitive variability of the antiproteinuric efficacy of RAS inhibitors in outpatients with IgA nephropathy.
    Suzuki T; Miyazaki Y; Shimizu A; Ito Y; Okonogi H; Ogura M; Utsunomiya Y; Kawamura T; Hosoya T
    Clin Nephrol; 2009 Oct; 72(4):274-85. PubMed ID: 19825333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms.
    Lang F; Cohen P
    Sci STKE; 2001 Nov; 2001(108):re17. PubMed ID: 11707620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of serum and glucocorticoid-inducible kinase-1 in kidneys of L-NAME-treated rats.
    Feng Y; Wang Y; Xiong J; Liu Z; Yard B; Lang F
    Kidney Blood Press Res; 2006; 29(2):94-9. PubMed ID: 16710099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria.
    Quinkler M; Zehnder D; Eardley KS; Lepenies J; Howie AJ; Hughes SV; Cockwell P; Hewison M; Stewart PM
    Circulation; 2005 Sep; 112(10):1435-43. PubMed ID: 16145013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of mice lacking the serum- and glucocorticoid-inducible kinase SGK1 against salt-sensitive hypertension induced by a high-fat diet.
    Huang DY; Boini KM; Osswald H; Friedrich B; Artunc F; Ullrich S; Rajamanickam J; Palmada M; Wulff P; Kuhl D; Vallon V; Lang F
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1264-73. PubMed ID: 17003223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY; Chang TI; Kang EW; Lim BJ; Kie JH; Kee YK; Kim H; Park S; Yun HR; Jung SY; Jhee JH; Kwon YE; Oh HJ; Park JT; Yoo TH; Kang SW; Jeong HJ; Han SH
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some metabolic and genetic risk factors and the progression of IgA nephropathy--preliminary report].
    Sulikowska B; Czarny J; Rość D; Odrowaz-Sypniewska G; Manitius J; Sliwka DM
    Pol Merkur Lekarski; 2006 Aug; 21(122):132-5; discussion 136. PubMed ID: 17144095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of sodium transport in mammalian collecting duct cells by aldosterone-induced kinase, SGK1: structure/function studies.
    Náray-Fejes-Tóth A; Helms MN; Stokes JB; Fejes-Tóth G
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):197-202. PubMed ID: 15134818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1.
    Artunc F; Ebrahim A; Siraskar B; Nasir O; Rexhepaj R; Amann K; Friedrich B; Risler T; Lang F
    Kidney Blood Press Res; 2009; 32(2):119-27. PubMed ID: 19401625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary liver-type fatty acid-binding protein: discrimination between IgA nephropathy and thin basement membrane nephropathy.
    Nakamura T; Sugaya T; Ebihara I; Koide H
    Am J Nephrol; 2005; 25(5):447-50. PubMed ID: 16118482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis.
    Zhang J; Lu X; Feng J; Li H; Wang S
    Biomed Res Int; 2021; 2021():9171715. PubMed ID: 34901280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.
    Lang F; Artunc F; Vallon V
    Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):439-48. PubMed ID: 19584721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.